Frequency News and Research

RSS

Arrowhead reports Phase 1 study data on ARC-520 for treatment of chronic hepatitis B infection

Arrowhead Research Corporation, a biopharmaceutical company developing targeted RNAi therapeutics, today announced that COO and Head of R&D, Bruce Given, M.D., presented data on the Phase 1 clinical study of ARC-520, the company's clinical candidate for the treatment of chronic hepatitis B infection, at the HepDART 2013 conference being held on The Big Island, Hawaii.

9 Dec 2013

Research explores epigenetic effects that contribute to psychiatric disorders in offspring

Advanced paternal age has been associated with greater risk for psychiatric disorders, such as schizophrenia and autism. With an increase in paternal age, there is a greater frequency of certain types of mutations that contribute to these disorders in offspring.

9 Dec 2013

LUTS likely to resolve without treatment

Lower urinary tract symptoms in men tend to follow a fluctuating course with marked variability in symptoms over time, a 5-year study has shown.

9 Dec 2013

Insomnia linked to increased GERD risk

Insomnia is associated with an increased risk for gastroesophageal reflux disease, findings from a cross-sectional study show.

9 Dec 2013

Majority of epilepsy surgery patients satisfied with results in improving psychological and social well-being

The majority of epilepsy patients who have brain surgery to treat their disorder are satisfied with the results in reducing epilepsy-related seizures and improving their psychological and social well-being.

9 Dec 2013

Study demonstrates safety and efficacy of NeuroPace RNS System in adults with intractable seizures

Researchers present the findings from a 2-year multicenter randomized double blinded controlled clinical study and a 7 year long-term treatment study of the NeuroPace RNS System at the American Epilepsy Society's 67th Annual Meeting.

9 Dec 2013

High frequency cell phone users have lower GPA, higher anxiety, and lower happiness in life

Today, smartphones are central to college students' lives, keeping them constantly connected with friends, family and the Internet. Students' cell phones are rarely out of reach whether the setting is a college classroom, library, recreational center, cafeteria or dorm room.

9 Dec 2013

Gene discovered to play a part in one per cent of all cancers

Researchers have identified a gene that drives the development of tumours in over one per cent of all cancer patients. This is the first time that the gene CUX1 has been broadly linked to cancer development.

9 Dec 2013

Auxilium Pharmaceuticals' XIAFLEX gets FDA approval for treatment of Peyronie's disease

Auxilium Pharmaceuticals, Inc., a fully integrated specialty biopharmaceutical company, announced today that the U.S. Food and Drug Administration has approved XIAFLEX (collagenase clostridium histolyticum, or CCH), an in-office, biologic for the treatment of Peyronie's disease. XIAFLEX is the first and only FDA-approved treatment proven effective for PD in men with a palpable plaque and a curvature deformity of 30 degrees or greater at the start of therapy.

6 Dec 2013

Cancer survival rates still vary widely between European countries

Cancer survival still varies widely between European countries despite major improvements in cancer diagnosis and treatment during the first decade of the 21st century, according to the latest EUROCARE-5 reports covering over 50% of the adult and 77% of the childhood population of Europe.

6 Dec 2013

Eisai reports new data analyses on FYCOMPA (Perampanel) at AES meeting

Today, Eisai Inc. announced that 16 abstracts highlighting new data analyses on FYCOMPA (perampanel) will be presented at the 67th annual American Epilepsy Society (AES) meeting, taking place in Washington, D.C. from December 6 – 10.

6 Dec 2013

INTENSIA family of ICDs and CRT-D devices receive CE mark approval

Sorin Group, a global medical company and a leader in the treatment of cardiovascular diseases, announced today that the INTENSIA family of implantable cardioverter defibrillators and cardiac resynchronization therapy devices received CE (Conformité Européenne) mark approval. This family of devices includes the single-chamber INTENSIA VR, the dual-chamber INTENSIA DR and the INTENSIA SonR® CRT-D devices, all of which feature a DF-4 high voltage connector.

6 Dec 2013

Baylor researchers study outcomes and effectiveness of traumatic brain injury rehabilitation

For patients recovering from a traumatic brain injury (TBI), the rehabilitation process - compensating for changes in functioning, adaptation and even community reintegration - can be challenging.

6 Dec 2013

Study examines correlation between polyunsaturated fatty acids in blood and risk of PTSD

A study published in the current issue of Psychotherapy and Psychosomatics has examined the correlation between polyunsaturated fatty acids in the blood and the risk of post-traumatic stress disorder.

6 Dec 2013

Cardiac patients benefit from home-based high intensity training

Rapid rehabilitation is a must after a heart attack or other cardiovascular event. Different forms of exercise as a part of rehabilitation have been examined by researchers, including high-intensity interval training (85-95 % of maximum heart rate), which has proved to be both a good and efficient form of rehabilitation.

5 Dec 2013

Genocea commences GEN-004 Phase 1 study to prevent pneumococcus infections

Genocea Biosciences, Inc., a clinical-stage company pioneering novel T cell vaccines, announced today that it has initiated a Phase 1 study of GEN-004, an investigational vaccine candidate for pneumococcus (Streptococcus pneumoniae), a major cause of infectious disease-related death globally. GEN-004 is the first vaccine candidate designed to prevent infections caused by all strains of pneumococcus through a novel T cell-mediated mechanism of action.

5 Dec 2013

Older people ingest too much magnesium, vitamin E in the form of dietary supplements

Many older people are ingesting too much magnesium and vitamin E in the form of dietary supplements. This was discovered by scientists of the Helmholtz Zentrum München in a population-based study; their results have been published in 'The Journal of Nutrition, Health and Aging'.

5 Dec 2013

Long-term ECG may help patients suffering from chronic cardiac insufficiency

Patients suffering from cardiac diseases may rapidly become emergencies. Then, seconds decide about life and death. However, many cardiac diseases are announced several months before. Symptoms are simply overlooked. A long-term ECG may help. A sensor belt developed at KIT for the first time allows to document cardiac activity of a patient over a long term all around the clock for up to six months. The sensor belt is now presented by the researchers at the Medica trade fair in Düsseldorf.

5 Dec 2013

New method for counting tumor-fighting cells to predict ovarian cancer

One way to predict survival of many types of cancer is by counting the number of tumor-attacking immune cells that have migrated into the tumor in an effort to eradicate it - a sign of the body's immune response to the cancer. However, quantifying these armies of immune cells has been difficult - until now.

5 Dec 2013

Update on reimbursement coverage for Percutaneous Tibial Nerve Stimulation procedures

Uroplasty, Inc. a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today provided an update on reimbursement coverage for Percutaneous Tibial Nerve Stimulation (PTNS) procedures delivered via the Company's Urgent® PC Neuromodulation System for treatment of overactive bladder (OAB) and associated symptoms of urinary urgency, urinary frequency and urge incontinence.

4 Dec 2013

Frequency News and Research

Arrowhead reports Phase 1 study data on ARC-520 for treatment of chronic hepatitis B infection

Research explores epigenetic effects that contribute to psychiatric disorders in offspring

LUTS likely to resolve without treatment

Insomnia linked to increased GERD risk

Majority of epilepsy surgery patients satisfied with results in improving psychological and social well-being

Study demonstrates safety and efficacy of NeuroPace RNS System in adults with intractable seizures

High frequency cell phone users have lower GPA, higher anxiety, and lower happiness in life

Gene discovered to play a part in one per cent of all cancers

Auxilium Pharmaceuticals' XIAFLEX gets FDA approval for treatment of Peyronie's disease

Cancer survival rates still vary widely between European countries

Eisai reports new data analyses on FYCOMPA (Perampanel) at AES meeting

INTENSIA family of ICDs and CRT-D devices receive CE mark approval

Baylor researchers study outcomes and effectiveness of traumatic brain injury rehabilitation

Study examines correlation between polyunsaturated fatty acids in blood and risk of PTSD

Cardiac patients benefit from home-based high intensity training

Genocea commences GEN-004 Phase 1 study to prevent pneumococcus infections

Older people ingest too much magnesium, vitamin E in the form of dietary supplements

Long-term ECG may help patients suffering from chronic cardiac insufficiency

New method for counting tumor-fighting cells to predict ovarian cancer

Update on reimbursement coverage for Percutaneous Tibial Nerve Stimulation procedures

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Latest News